Delivery Order SPE2DB24D2100-SPE2DB25FBFUE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,097.06 to AmerisourceBergen Drug Corp for CombiPatch 0.05-0.14 mg transdermal patches (8-count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside award, meaning it was competitively awarded without restrictions to small businesses or other designated groups. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,231.17 in Combipatch transdermal patches (0.05-0.14 mg), with an ultimate completion date of August 15, 2025. This competitive award, issued on August 14, 2025, carries a firm fixed price structure and involves no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,094.93 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.14 MG patches (8-count) on August 8, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a $3,430.71 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Combipatch 0.05-0.14 mg transdermal patches (8-count units). This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. Performance is scheduled for completion by September 3,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for COMBIPATCH 0.05-0.14 mg patches in a quantity of 8 units. This is a firm fixed price delivery order with a ceiling value of $1,743.72 and an ultimate completion date of August 14, 2025. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,136.83 to AmerisourceBergen Drug Corp for COMBIPATCH 0.05-0.25 mg patches (8-count) with an ultimate completion date of August 18, 2025. This non-set-aside contract was competitively awarded and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,791.52 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Combipatch 0.05-0.14 mg patches (8-count units). This is a firm fixed price, non-set-aside contract with a completion date of July 31, 2025, and performance occurring at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency awarded a $581,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. Under this single day contract, Amerisourcebergen will supply 8,000 boxes of the 0.05-0.25 mg dosage patches to a Conshohocken, Pennsylvania facility from August 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the combination estrogen and progestin patches supports the...
- The Defense Logistics Agency awarded a $985 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. The patches will be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania under a one-day period of performance from August 16-17, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity contract vehicle....
- The Defense Logistics Agency awarded a $745.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. As the prime contractor, Amerisourcebergen will deliver the medication to the DLA under a one-day period of performance beginning July 10th and concluding on July 11th, 2023. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. This order is likely...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFUEDelivery Order
The Defense Logistics Agency awarded a $1,695.21 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for CombiPatch 0.05-0.14 mg transdermal patches (eight-count units). This firm fixed-price delivery order, with a completion date of August 13, 2025, represents a small-value pharmaceutical procurement under a non-competitive set-aside arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $1 billion global pharmaceutical support vehicle valued through December 2026. The IDC serves as a comprehensive procurement vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor serving Defense Health Agency and other federal healthcare systems through competitively awarded contracts with consistent firm fixed-price delivery order arrangements across therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/12/25 |